News und Analysen

Any time is a good time for income investors to buy dividend stocks. But certain times are better than others for specific stocks.

I think that's the case for several great picks with a new month

Biogen's (NASDAQ: BIIB) biggest problem in recent times has been growth. The biotech giant's multiple sclerosis (MS) portfolio is facing more and more generic competition, and that's resulted in

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

The last time

News of a fresh COVID-19 surge sent numerous stockholders into the shares of vaccine maker Novavax (NASDAQ: NVAX) on the first trading day of the week. As a result, Novavax's shares popped more than

Eli Lilly (NYSE: LLY) and Biogen (NASDAQ: BIIB) will soon likely be going head to head in the market for therapies that treat Alzheimer's disease. Both drug developers see the market for such

Shares of Reata Pharmaceuticals (NASDAQ: RETA) recently jumped about 54% higher in a single trading session. This biotech stock was already way up this year thanks to the recent approval of its

Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) both are approaching a crucial moment in their stories. The biotech companies are awaiting regulatory decisions for

A high price tag sometimes indicates value, be it in equity markets or elsewhere. Still, excellent stocks can be had for a relatively modest sum. With just $100 or even less, investors can get their

The stock market has rallied so far this year, particularly in the period between the last earnings season and this one. Companies now have to prove to Wall Street that their higher stock prices are

GSK (NYSE: GSK), a global healthcare company, initiated the separation of its consumer healthcare business, Haleon, last year, as part of its ambitious restructuring plan that CEO Emma Walmsley

AT&T (NYSE: T) posted its second-quarter report on July 26. Its revenue rose 1% year over year to $29.9 billion, which missed analysts' estimates by $30 million. Its adjusted earnings per share

Animal health company Zoetis (NYSE: ZTS) and pharmaceutical giant Eli Lilly (NYSE: LLY) are healthcare companies that are off to solid starts this year, with Zoetis' shares up more than 30% and

Medtronic (NYSE: MDT) is a top medical device maker that pays a high dividend. With operations in 150 countries with products helping people with more than 70 different health conditions, it has a

Investors haven't been a fan of AT&T (NYSE: T) stock in 2023, but that may be starting to change as performance begins to improve. In this video, Travis Hoium covers the latest numbers and why AT&T

It's been a tough few years for telecom giant AT&T (NYSE: T). In retrospect, its decisions to acquire DirecTV and then Time Warner were not only ill-advised, but expensive. Those deals have since

Dividend stocks can practically be a retiree's best friend. At least, the right ones can be. Three Motley Fool contributors were asked to identify healthcare dividend stocks they think retirees

Fool.com contributor Parkev Tatevosian reviews AT&T's (NYSE: T) latest earnings release to determine if it's an excellent dividend stock.

*Stock prices used were the afternoon prices of July 27

Image source: The Motley Fool.

AstraZeneca Plc (NASDAQ: AZN)Q2 2023 Earnings CallJul 28, 2023, 6:45 a.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

Centene (NYSE: CNC)Q2 2023 Earnings CallJul 28, 2023, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of Genelux (NASDAQ: GNLX) were up 14.8% for the week, as of 9:30 a.m. ET Friday, according to data provided by S&P Global Market Intelligence. The clinical-stage biotech company's stock

In June, UnitedHealth Group (NYSE: UNH) alerted investors that its costs were creeping up due to increasing demand for surgeries. That led to a decline in the share price heading into the company's

With a market cap of $472 billion and tens of millions of people covered under its plans, UnitedHealth Group (NYSE: UNH) is the undisputed king of health insurance stocks. But over the last 12

Fool.com contributor Parkev Tatevosian compares Nano Dimension (NASDAQ: NNDM) and Invitae (NYSE: NVTA) across critical financial variables, including valuation, to determine the better stock to buy